Faculty Opinions recommendation of White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.

2019 ◽  
Author(s):  
Luis Ruilope
Keyword(s):  
General Population ◽  
White Coat ◽  
Masked Hypertension

2.4 White Coat and Masked Hypertension Increase the Risk of New Onset Sustained Hypertension in the General Population

2008 ◽  
Vol 15 (3) ◽  
pp. 186-186
Author(s):  
M. Bombelli ◽  
H. Polo Friz ◽  
F. Ganz ◽  
S. Buzzi ◽  
I. Ronchi ◽  
...  
Keyword(s):  
General Population ◽  
White Coat ◽  
Masked Hypertension ◽  
Sustained Hypertension ◽  
New Onset

White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study

2017 ◽  
Vol 40 (11) ◽  
pp. 937-943 ◽  
Author(s):  
Jun Hata ◽  
Masayo Fukuhara ◽  
Satoko Sakata ◽  
Hisatomi Arima ◽  
Yoichiro Hirakawa ◽  
...  
Keyword(s):  
General Population ◽  
White Coat ◽  
Masked Hypertension

scholarly journals White-Coat and Masked Hypertension Are Associated With Carotid Atherosclerosis in a General Population

Stroke ◽  
2013 ◽  
Vol 44 (6) ◽  
pp. 1512-1517 ◽  
Author(s):  
Masayo Fukuhara ◽  
Hisatomi Arima ◽  
Toshiharu Ninomiya ◽  
Jun Hata ◽  
Yoichiro Hirakawa ◽  
...  
Keyword(s):  
General Population ◽  
Carotid Atherosclerosis ◽  
White Coat ◽  
Masked Hypertension

[PP.06.15] DETERMINANTS OF WHITE-COAT AND MASKED HYPERTENSION IN THE GENERAL POPULATION

2017 ◽  
Vol 35 ◽  
pp. e133-e134
Author(s):  
K.G. Kyriakoulis ◽  
A. Ntineri ◽  
P.G. Kalogeropoulos ◽  
E.K. Aissopou ◽  
G.S. Stergiou
Keyword(s):  
General Population ◽  
White Coat ◽  
Masked Hypertension

MO501INCREASED ALBUMINURIA RISK IN CHRONIC KIDNEY DISEASE PATIENTS WHOSE WHITE COAT-, MASKED-, AND SUSTAINED HYPERTENSION: SYSTEMATIC REVIEW AND META-ANALYSIS

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Boby Pratama Putra ◽  
Felix Nugraha Putra
Keyword(s):  
Meta Analysis ◽  
Blood Pressure Measurement ◽  
Target Organ Damage ◽  
Random Effect ◽  
White Coat ◽  
Cochrane Library ◽  
White Coat Hypertension ◽  
Masked Hypertension ◽  
Sustained Hypertension ◽  
Standard Mean Difference

Abstract Background and Aims Latest classification of hypertension based on ambulatory blood pressure measurement was normotension (NT), white coat hypertension (WCHT), masked hypertension (MHT), and sustained hypertension (SHT). Recent studies suggest that WCHT, MHT, and SHT increase risk of target organ damage, particularly albuminuria, although the results were still inconsistent. Albuminuria is not only the sign of early glomerular damage in CKD patients, but also the signs of hypertension progression and predictors for cardiovascular events mortality. This study aims to compare the albuminuria risk among NT and WCHT, MHT, also SHT in CKD patients. Method We searched the literature comprehensively in online databases of Pubmed, EMBASE, ScienceDirect, and Cochrane Library to include all relevant studies using predefined terms until December 2020. We included studies that analyzed the albuminuria risk and compared the log2 urinary albumin-to-creatinine ratio (ACR) among NT and WCHT, MHT, or SHT in CKD patients. We used the Newcastle-Ottawa Scale for Observational Study checklist for evaluating bias risks. Analysis of the studies was conducted to provide pooled Odds Ratio (OR) for albuminuria risk and standard mean difference (SMD) for log2 ACR comparison with 95% Confidence Interval (CI) with random-effect heterogeneity test. Results We included 7 observational studies met our inclusion criteria. WCHT increases albuminuria risk although not statistically significant (pooled OR = 1.72, 95%CI 0.97 to 3.07, p = 0.06, I2 = 75%), while MHT and SHT significantly increase albuminuria risk with pooled OR respectively 1.62 (95%CI 1.03 to 2.53, p = 0.04, I2 = 82%) and 3.17 (95%CI 1.66 to 6.05, p = 0.0005, I2 = 94%). Controlled hypertension significantly protects CKD patients against albuminuria risk based on log2 ACR comparison with WCHT (SMD = 0.52, 95%CI 0.38 to 0.67, p<0.00001, I2 = 0%), MHT (SMD = 0.34, 95%CI 0.19 to 0.49, p<0.0001, I2 = 39%), and SHT (SMD = 0.63, 95%CI 0.31 to 0.95, p=0.0001, I2 = 76%). Conclusion White coat hypertension, masked hypertension, and sustained hypertension increase albuminuria risks in CKD patients. However, further studies are needed to determine the causality.

scholarly journals White-coat hypertension and masked hypertension: an update

2015 ◽  
Vol 9 (3) ◽  
Author(s):  
Nathan Artom ◽  
Francesco Salvo ◽  
Francesca Camardella
Keyword(s):  
Cardiovascular Disease ◽  
White Coat ◽  
White Coat Hypertension ◽  
Masked Hypertension ◽  
Search Terms ◽  
Clinical Consequences ◽  
In The Beginning

White coat hypertension and masked hypertension are two conditions with a controversial role in the beginning and the progression of the cardiovascular disease. We focused our attention to the definition, the epidemiology, the pathophysiology and the clinical consequences of these two conditions, with an attention also to the management. This review was based on the papers found on PubMed and MEDLINE up to August 2015. The search terms used were <em>white coat hypertension</em>, <em>masked hypertension</em> in combination with <em>epidemiology, management and pathophysiology</em>.

[PP.26.07] HBPM VS. ABPM IN DETECTION OF MASKED HYPERTENSION IN THE SLOVENIAN GENERAL POPULATION

2017 ◽  
Vol 35 ◽  
pp. e307-e308
Author(s):  
J. Brguljan ◽  
J. Knez ◽  
N. Bozic ◽  
J. Lajovic ◽  
R. Accetto ◽  
...  
Keyword(s):  
General Population ◽  
Masked Hypertension

Abstract 11530: Age-Specific Differences Between Conventional and Ambulatory Daytime Blood Pressure Values

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
David Conen ◽  
Stefanie Aeschbacher ◽  
Lutgarde Thijs ◽  
Yan Li ◽  
José Boggia ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Population Based ◽  
White Coat ◽  
White Coat Hypertension ◽  
Masked Hypertension ◽  
Daytime Blood Pressure ◽  
Collaborative Analysis ◽  
The Individual ◽  
Age Range ◽  
Diagnosis Of Hypertension

Introduction: Mean daytime ambulatory blood pressure (ABP) values are considered to be lower than conventional BP (CBP) values, but data on this relation among younger individuals <50 years are scarce. To address this issue, we performed a collaborative analysis in a large group of participants representing a wide age range. Methods: CBP and 24-hour ABP were measured in 9550 individuals not taking BP lowering treatment from 13 population based cohorts. We compared the individual differences between daytime ABP and CBP according to 10-year age categories. Age-specific prevalences of white-coat hypertension and masked hypertension were calculated based on guideline-recommended thresholds. Results: Among individuals aged 18-30, 30-40 and 40-50 years, mean daytime systolic and diastolic ABP were significantly higher than the corresponding CBP (6.0, 5.2 and 4.7 mmHg for systolic BP; 2.5, 2.7 and 1.7 mmHg for diastolic BP, all p<0.0001) (Figure). Systolic and diastolic BP indices were similar in participants aged 50-60 years (p=0.20 and 0.11, respectively). In individuals aged 60-70 and ≥70 years, CBP was significantly higher than daytime ABP (5.0 and 13.0 mmHg for systolic BP; 2.0 and 4.2 mmHg for diastolic BP, all p<0.0001) (Figure). Accordingly, the prevalence of white coat hypertension exponentially increased from 2.2% to 19.5% from those aged 18-30 years to those aged ≥70 years, with some variation between men and women (prevalence 8.0% versus 6.1%, p=0.0003). Masked hypertension was more prevalent among men (21.1% versus 11.4%, p<0.0001). The age-specific prevalence of masked hypertension was 18.2%, 27.3%, 27.8%, 20.1% 13.6% and 10.2% in men, and 9.0%, 9.9%, 12.2%, 11.9%, 14.7% and 12.1% in women. Conclusions: In this large collaborative analysis we found that the relation between daytime ABP and CBP strongly varies by age. These findings may have important implications for the diagnosis of hypertension and its subtypes in clinical practice.

Sign in / Sign up

Export Citation Format

Share Document